Levetiracetam

CAS 102767-28-2 36 current records 11 historicalSmall Molecule

Who holds supplier records for Levetiracetam? 36 organisations hold a current record for Levetiracetam: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 32 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (25) and China (9); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Levetiracetam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/levetiracetam

Reading the evidence

  • 36 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    25 of the 34 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 20 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Levetiracetam expires 14 Mar 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (36)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Levetiracetam. Country is the organisation's recorded country, not necessarily the manufacturing site.

India25China9Country not recorded for 2
  • Divis Laboratories
    Active DMF 30185, 16894 · latest filing Jan 2016
    IndiaCEP Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 30626, 17738 · latest filing Jun 2016
    IndiaCEP Company GMP cert on record
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
    Active DMF 30119, 22235, 37852 +1 · latest filing Dec 2022
    ChinaCEP Company GMP cert on record
  • AMOLI ORGANICS PRIVATE LTD
    Active DMF 23585, 25762 · latest filing Feb 2012
    IndiaCEP
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 19387 · latest filing Apr 2006
    IndiaCEP Company GMP cert on record
  • Aurore Life Sciences
    Active DMF 34097 · latest filing Aug 2019
    IndiaCEP Company GMP cert on record
  • CHIERON ACTIVE INGREDIENTS PRIVATE LTD
    Active DMF 35316 · latest filing Oct 2020
    IndiaCEP
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 16966 · latest filing Nov 2003
    IndiaCEP Company GMP cert on record
  • EMNAR PHARMA PRIVATE LTD
    Active DMF 35441 · latest filing Dec 2020
    IndiaCEP
  • Granules India Limited
    Active DMF 37775 · latest filing Dec 2022
    IndiaCEP Company GMP cert on record
  • INNOVARE LABS PRIVATE LTD
    Active DMF 34593 · latest filing Feb 2020
    IndiaCEP
  • Iol Chemicals And Pharmaceuticals Limited
    Active DMF 36374 · latest filing Nov 2021
    IndiaCEP Company GMP cert on record
  • JUBILANT BIOSYS LTD
    Active DMF 24200 · latest filing Oct 2010
    IndiaCEP
  • Lupin Limited
    Active DMF 19080 · latest filing Dec 2005
    IndiaCEP Company GMP cert on record
  • MSN LIFE SCIENCES PRIVATE LIMITED
    Active DMF 33608 · latest filing Feb 2019
    IndiaCEP Company GMP cert on record
  • Neuland Laboratories Limited
    Active DMF 17799 · latest filing Nov 2004
    IndiaCEP
  • RUI Laboratories Private Limited
    Active DMF 41245 · latest filing Mar 2025
    IndiaCEP
  • SMS Pharmaceuticals limited
    Active DMF 28431 · latest filing Jun 2014
    IndiaCEP Company GMP cert on record
  • SOLARA ACTIVE PHARMA SCIENCES LTD
    Active DMF 26500 · latest filing Sept 2012
    IndiaCEP Company GMP cert on record
  • SRINI PHARMACEUTICALS PRIVATE LIMITED
    Active DMF 24757 · latest filing Mar 2011
    IndiaCEP Company GMP cert on record
  • Sun Pharmaceutical Industries Limited
    Active DMF 21414 · latest filing Mar 2008
    IndiaCEP Company GMP cert on record
  • Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
    Active DMF 25005 · latest filing May 2011
    ChinaCEP
  • Hubei Shinewell Pharmaceutical Co., Ltd.
    Active DMF 44329 · latest filing Jun 2026
    China
  • ORBION PHARMACEUTICALS PRIVATE LTD
    Active DMF 19747 · latest filing Sept 2006
    India Company GMP cert on record
  • SHAOXING JINGXIN PHARMACEUTICALS CO LTD
    Active DMF 35629 · latest filing Apr 2021
    China
  • VASUDHA PHARMA CHEM LTD
    Active DMF 38130 · latest filing Mar 2023
    India
  • ESTEVE QUIMICA SA
    Inactive DMF 17327 · latest filing Apr 2004
    CEP Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • SECOND PHARMA CO LTD
    Inactive DMF 25120 · latest filing Jun 2011
    ChinaCEP
  • Shaoxing Jingxin Pharmaceutical Co., Ltd.
    ChinaCEP
  • ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTD
    CEP Company GMP cert on record
  • Zhejiang Jiangbei Pharmaceutical Co., Ltd.
    Inactive DMF 34222 · latest filing Dec 2019
    ChinaCEP
  • WEIFANG HISHINE PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
  • ABA CHEMICALS (SHANGHAI) LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Levetiracetam sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (32)

Certificates of Suitability on the EDQM register for Levetiracetam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 47 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
WEIFANG HISHINE PHARMACEUTICAL CO., LTD. WeifangCN
CEP 2011-035 - Rev 06
Levetiracetam
Sept 2026—
INNOVARE LABS PRIVATE LIMITED VisakhapatnamIN
CEP 2019-269 - Rev 01
Levetiracetam
Sept 2026—
SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. ShangyuCN
CEP 2021-267 - Rev 02
Levetiracetam, Process II
Jul 2026—
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2011-380 - Rev 09
Levetiracetam
Jul 2026—
IOL CHEMICALS AND PHARMACEUTICALS LIMITED LudhianaIN
CEP 2021-343 - Rev 01
Levetiracetam
Jun 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2010-245 - Rev 05
Levetiracetam
Mar 2026—
ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai CityCN
CEP 2023-031 - Rev 01
Levetiracetam, Site 2
Mar 2026Inspected Oct 2025
France
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2011-159 - Rev 02
Levetiracetam
Jan 2026—
CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED HyderabadIN
CEP 2023-046 - Rev 02
Levetiracetam
Dec 2025—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2021-034 - Rev 01
Levetiracetam
Oct 2025—
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2021-196 - Rev 01
Levetiracetam, Form I
Sept 2025—
GRANULES INDIA LIMITED HyderabadIN
CEP 2023-138 - Rev 01
Levetiracetam
Aug 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2011-084 - Rev 02
Levetiracetam
May 2025—
SRINI PHARMACEUTICALS PRIVATE LIMITED ChoutuppalIN
CEP 2018-176 - Rev 01
Levetiracetam
Feb 2025Inspected Sept 2025
Sweden
HETERO LABS LIMITED HyderabadIN
CEP 2014-113 - Rev 02
Levetiracetam, Form-I Process-II
Nov 2024—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2012-324 - Rev 02
Levetiracetam
Oct 2024—
LAURUS LABS LIMITED HyderabadIN
CEP 2023-133 - Rev 00
Levetiracetam
Sept 2024—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
CEP 2022-399 - Rev 01
Levetiracetam, Process VII, micronised and non-micronised
Aug 2024Inspected May 2026
Italy
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2024-009 - Rev 00
Levetiracetam
Aug 2024—
LUPIN LIMITED MumbaiIN
CEP 2013-242 - Rev 03
Levetiracetam
Mar 2024—
MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor VillageIN
CEP 2019-300 - Rev 03
Levetiracetam
Mar 2024—
EMNAR PHARMA PRIVATE LIMITED HyderabadIN
CEP 2021-500 - Rev 01
Levetiracetam
Oct 2023—
Rui Laboratories Private Limited VisakhapatnamIN
R0-CEP 2021-444 - Rev 00
Levetiracetam
Jun 2023—
EXEMED PHARMACEUTICALS VadodaraIN
R0-CEP 2020-199 - Rev 00
Levetiracetam
Jun 2022—
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
R1-CEP 2014-270 - Rev 00
Levetiracetam
Sept 2021—
ABA CHEMICALS (SHANGHAI) LIMITED ShanghaiCN
R1-CEP 2015-035 - Rev 00
Levetiracetam
Aug 2021—
ESTEVE QUIMICA S.A. BarcelonaES
R1-CEP 2011-042 - Rev 05
Levetiracetam, Code product 2577
Jun 2021—
SECOND PHARMA CO., LTD. Shangyu CityCN
R1-CEP 2014-219 - Rev 00
Levetiracetam
Dec 2020—
SMS PHARMACEUTICALS LIMITED HyderabadIN
R1-CEP 2014-275 - Rev 00
Levetiracetam
Dec 2020—
DIVI'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2014-079 - Rev 01
Levetiracetam, Process B
Dec 2020—
ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD. Taizhou CityCN
R1-CEP 2012-084 - Rev 03
Levetiracetam
Sept 2020—
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. HengdianCN
R1-CEP 2013-246 - Rev 00
Levetiracetam
Mar 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (11)

Organisations whose Type II DMFs for Levetiracetam are no longer active. These show a past filing, not current supply.

Show all 11 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (153 listed products contain Levetiracetam). The latest listed patent expires 14 Mar 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Levetiracetam is an anticonvulsant medication used to treat epilepsy. It is known to inhibit burst firing without affecting normal neuronal excitability, thereby preventing the propagation of seizure activity.

Chemical identity

IUPAC name
2-(2-oxopyrrolidin-1-yl)butanamide
Canonical SMILES
CCC(C(=O)N)N1CCCC1=O
InChIKey
HPHUVLMMVZITSG-UHFFFAOYSA-N
Synonyms
Keppra API, Etiracetam, 2-(2-oxopyrrolidin-1-yl)butanamide, alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, Etiracetamum, UCB-6474, RefChem:139255, UCB 6474, Etiracetam [INN], Levetiracetam-d3, (R)-Levetiracetam, Etiracetamum [INN-Latin]

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Physiologic effect
Decreased Central Nervous System Disorganized Electrical Activity

Therapeutic areas

NeurologyEpilepsyAnticonvulsants

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Levetiracetam?

36 organisations hold an active US FDA Type II Drug Master File or a CEP for Levetiracetam: Divis Laboratories (India), Hetero Labs Limited (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), AMOLI ORGANICS PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Aurore Life Sciences (India), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (India) and Dr. Reddy's Laboratories Ltd. (India), and 28 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Levetiracetam Drug Master Files are active?

Divis Laboratories (DMF 30185, 16894), Hetero Labs Limited (DMF 30626, 17738), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 30119, 22235), AMOLI ORGANICS PRIVATE LTD (DMF 23585, 25762), APITORIA PHARMA PRIVATE LTD (DMF 19387), Aurore Life Sciences (DMF 34097), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (DMF 35316) and Dr. Reddy's Laboratories Ltd. (DMF 16966) and 18 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Levetiracetam records mean?

11 organisations have only inactive Type II DMFs for Levetiracetam. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Levetiracetam have a European Certificate of Suitability?

Yes. 32 organisations hold a valid CEP for Levetiracetam on the EDQM register, including WEIFANG HISHINE PHARMACEUTICAL CO., LTD. Weifang (CN), INNOVARE LABS PRIVATE LIMITED Visakhapatnam (IN), SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu (CN), NEULAND LABORATORIES LIMITED Hyderabad (IN), IOL CHEMICALS AND PHARMACEUTICALS LIMITED Ludhiana (IN) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and 26 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Levetiracetam?

Yes. The latest patent listed for an approved US product containing Levetiracetam expires 14 Mar 2034, across 153 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Levetiracetam supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Levetiracetam?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.